Cloxacillin sodium salt monohydrate CAS:7081-44-9
Cloxacillin sodium salt monohydrate is utilized in the management of bacterial infections caused by susceptible organisms. It is particularly effective against staphylococcal infections, including methicillin-sensitive Staphylococcus aureus (MSSA). Common conditions treated with cloxacillin sodium salt monohydrate include skin and soft tissue infections, respiratory tract infections, bone infections, and other localized or systemic bacterial infections. It is essential to follow the prescribed dosing regimen provided by a healthcare professional when using cloxacillin sodium salt monohydrate to ensure optimal therapeutic outcomes and minimize the risk of resistance development. The duration of treatment and dosage may vary based on the type and severity of the infection. Prior to initiating treatment with cloxacillin sodium salt monohydrate, it is important to disclose any known allergies or sensitivities to antibiotics. Monitoring for potential side effects, which can include gastrointestinal disturbances, allergic reactions, and hepatic toxicity, is crucial during therapy. In conclusion, cloxacillin sodium salt monohydrate is a valuable antibiotic agent for combating bacterial infections and should be used responsibly to maintain its effectiveness and minimize the emergence of resistant strains.
Composition | C19H19ClN3NaO6S |
Assay | 99% |
Appearance | white powder |
CAS No. | 7081-44-9 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |